Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
STRASBOURG, France & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies ...